Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral prednisolone versus intratympanic dexamethasone for sudden sensorineural hearing loss
IRCT20120215009014N422Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in acute sensorineural hearing loss comparing Intratympanic dexamethasone with Oral prednisolone (2 arms). Primary endpoint: Hearing threshold. Started May 2021; status: completed.
02
Drugs
prednisolonedexamethasone
03
Conditions
acute sensorineural hearing loss
Beyond the preview
Go deeper on IRCT20120215009014N422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N422.